UZBrussel
Jette, Brussels Capital, 1090, Belgium
NCT Number: NCT03346174
The purpose of this study is to determine whether Assisted Autogenic Drainage (AAD) or bouncing combined with Assisted Autogenic Drainage (BAAD), induces or aggravates acid and non-acid gastro-oesophageal reflux in infants under the age of one year. Infants, referred to the hospital for impedance-pH monitoring are included in this study.
Looking for future studies?
Notify Me1 day–365 day
All sexes
Interventional
Not applicable
Jette, Brussels Capital, 1090, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In this controlled trial with intra-subject design infants will be studied using multichannel intraluminal impedance pH (pH-MII) monitoring , during which they receive one 20 min session of AAD . The number of reflux episodes (RE) is the outcome measure. The results obtained during and 20 min after the intervention will be compared to a period of 20 min before treatment ( control ).
In this controlled trial with intra-subject design infants will be studied using multichannel intraluminal impedance pH (pH-MII) monitoring , during which they receive one 20 min session of BAAD . The number of reflux episodes (RE) is the outcome measure. The results obtained during and 20 min after the intervention will be compared to a period of 20 min before treatment ( control ).
Time frame: 20 minutes
Time frame: 20 minutes
Time frame: 20 minutes
Vrije Universiteit Brussel
Other
Influence of Assisted Autogenic Drainage (AAD) and Bouncing Combined With Assisted Autogenic Drainage (BAAD) on Acid and Non-acid Gastro-oesophageal Reflux (GOR) in Infants < 1 Year
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02457429
Deglutition Disorders, Digestive System Diseases
Manchester, United Kingdom
View Trial DetailsNCT02620241
Deglutition Disorders, Digestive System Diseases
Jette, Brussels Capital, Belgium
View Trial DetailsNCT02124863
Deglutition Disorders, Digestive System Diseases
Jette, Brussels Capital, Belgium
View Trial DetailsNCT01601379
Deglutition Disorders, Digestive System Diseases
View Trial Details